Qloudlab has developed Sceptre, a remote test device that enables at “home” blood cholesterol test or measure urea in urine.

Perform blood tests with your smartphone screen

SCEPTRE uses a patented & modular architecture to offer you a personalized diagnostic device.

Each module delivers a unique set of diagnostics, and whether you want to perform a blood cholesterol test or measure urea in urine.

Qloudlab has developed Sceptre, a remote blood test device that enables at “home” blood monitoring; cloud linked to your doctor,empowering him/her to remotely monitor and improve your care through optimization of your treatment.



Qloudlab’s mobile application guide you through the testing procedure and shows you the test results. All generated results can be stored on a secured cloud accessible wherever you are. Compatible with all module.

Sceptre performs the sample analysis and sends the test results back to your mobile device. The Sceptre integrates a modular port so different module can be inserted depending of the tests to be performed.


Full lipid tests strip using a single blood drop (Total Cholesterol, HDL, LDL, Triglycerides)

Current POCT readers are creating isolated data that cannot be used for remote monitoring, secured online storage and trend analysis. On the other side Sceptre was engineered from the start to share the test results in the most convenient ways.




Qloudlab says the sensors normally used for finger tracking can also be used for … detection of molecules, making blood coagulation testing possible.

The device works by detecting a molecule present in blood that initiates coagulation and analysing the disruption to the electrical field present in most touchscreen devices, with the results interpreted by Qloudlab’s smartphone app.


Patients undergoing treatment for the prevention of blood clots require frequent blood tests and it is hoped that the device could allow patients to conveniently self-monitor their condition.


The gadget is able to indicate coagulation in under a minute, providing a fast test that could limit the chances of patients developing potentially fatal blood clots in their arteries and veins. The wrong dosage of anti-coagulants can cause serious cardiovascular problems and the ability to self-monitor, as many diabetics do, is seen as a potential lifesaver.

Qloudlab’s technology is still being tested, but if it works it could be a welcome change for patients who need to frequently check their blood.





Leave a Reply

Your email address will not be published. Required fields are marked *